EBRD, DPI and BII exit from KELIX bio
EBRD, DPI, and BII have announced the sale of KELIX bio, a prominent emerging-market biopharmaceutical platform, to Mubadala Investment Company.KELIX...
EBRD, DPI, and BII have announced the sale of KELIX bio, a prominent emerging-market biopharmaceutical platform, to Mubadala Investment Company.KELIX...